|
|
 |
News
|
< Back to Main News Page
Location And Directions... |
The Trinitas Comprehensive Cancer Center is located at our Williamson
St. Campus.
|
TCCC APPOINTED MEMBER OF PRESTIGIOUS RADIATION THERAPY ONCOLOGY GROUP
Trinitas Comprehensive Cancer Center (Trinitas CCC) opened its doors in 2005
with a mission: to become a regional leader in the delivery of state-of-the-art
cancer care and a pioneer in exploring new and improved technologies in curing
cancer. In reaching toward this goal, Trinitas CCC announces that it is now
approved as an active Member of the prestigious Radiation Therapy Oncology Group
(RTOG) based in the offices of the American College of Radiology Clinical
Research in Philadelphia.
The Radiation Therapy Oncology Group is a national clinical trials cooperative
group funded by the National Cancer Institute (NCI) to investigate new protocols
related to the care and treatment of many of the most common types of cancer.
The group consists of both clinical and laboratory investigators from more than
260 of the most qualified institutions across the United States and Canada.
Since its inception 35 years ago, RTOG member institutions have investigated
more than 300 protocols on about 60,000 patients. In addition, RTOG members have
helped define new national standards of care and new strategies to improve the
survival and quality of life for many. Only approximately 10% of all radiation
therapy facilities in the U.S. have been approved for RTOG membership.
Requirements for appointment in RTOG are stringent. An Affiliate Member
institution must maintain a full-time staff with expertise in a range of
required oncological disciplines including medical oncology, surgery, and
pathology, as well as expertise in research and data management. In addition,
the institution must maintain high quality and be proficient in calibration and
treatment planning procedures as recommended by the American Association of
Physicists in Medicine (AAPM). Furthermore, the institution must possess
advanced planning and treatment technology. In this regard, Trinitas CCC was the
first cancer center in New Jersey to house the advanced Trilogy linear
accelerator.
"Being approved for membership in the RTOG is a confirmation that Trinitas
continues to raise the level of cancer care in our region," said Gary S. Horan
FACHE, President and CEO of Trinitas Hospital, adding, "This is the culmination
of a major commitment we made in 2005. We owe this RTOG affiliation to our
outstanding team of medical specialists, research staff, and support staff whose
activities are directed to helping people with cancer to live longer with a
better quality of life."
Presiding as Chair of Radiation Oncology at Trinitas CCC is Dr. Clarissa Febles
Henson, who worked with her staff in applying for and successfully qualifying
for membership in the RTOG. Dr. Henson announced the appointment saying,
"Membership in the RTOG represents a significant increase in access to
multi-institutional protocols and clinical trial options for patients in Union
County and throughout New Jersey."
For more information, or to speak with Dr. Clarissa Febles Henson, please call
908-994-8000.